Leptomenigeal Metastasis, MC Onco 54

download Leptomenigeal Metastasis, MC Onco 54

of 14

Transcript of Leptomenigeal Metastasis, MC Onco 54

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    1/14

    Medical ConferenceLeptomeningeal metastasis: clinical

    manifestation and diagnosis

    Surat TanprawateDivision of NeurologyChiang Mai University

    27 Jan 2011

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    2/14

    Cancer and the

    nervous s stem Primary nervous system tumor

    Nervous system metastasis Paraneoplastic syndrome

    Indirect neurological complication fromcancer

    Complication from therapy

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    3/14

    Leptomeningeal

    metastasis 5% of cancer patient have LM metastasis

    The incidence varies with different tumor

    types

    8% of patient with solid tumor

    5-29% of patient with non-Hodgkinslymphoma

    11-70% of leukemia patients

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    4/14

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    5/14

    Kesari, S. Neurol Clin N Am21 (2003) 2566

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    6/14

    Leptomeninges=arachnoid+pia mater

    Anatomy of Leptomeninges

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    7/14

    Pathogenesis

    Direct extensionbrain parenchymaepidural space

    Hematogenous

    spreading

    CSF flow

    Spread along thesurface of the

    brain, spinal cord,

    and nerve root

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    8/14

    Neurologicaldysfunction

    Direct compression of brain structure bymeningeal nodule (focal symptoms)

    Irritate adjacent brain (seizure)

    Blocking of CSF pathways (leading tohydrocephalus and raised

    intracranial pressure)

    Ischemia, or stroke (by constriction of pialarteries)

    Cranial and peripheral nerve palsies (bydirect nerve involvement)

    Metabolic derangements (by decreasingavailable glucose for brain by rapidly

    growing tumor cells)

    Meningeal fibrosis

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    9/14

    Signs and symptoms of leptomeningeal metastasis

    Cancer Invest2000;18:38194

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    10/14

    Case scenario

    high index of suspicious

    History of cancer Multiple neurological symptoms

    Sign of meningeal irritation- present

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    11/14

    Neuro-imaging

    Enhancement may be

    linear or nodular

    Kesari, S. Neurol Clin N Am21 (2003) 2566

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    12/14

    CSF finding

    CSF findings increased protein (most cases) reduced glucose (25 to 30%)

    lymphocytic pleocytosis (50%) elevated opening pressure(50%)

    Thursday, 27 January 2011

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    13/14

    Diagnostic test

    Test Measurement Positive findings

    Lumbar puncture

    Lymphocytic pleocytosis

    Elevate OP

    Elevate protein

    Reduced glucoseCytology after 1 LP

    Cytology after 3 LP

    Immunohistochemistry

    PCR

    >70%

    50%

    75%

    30-40%50%

    90%

    Variable

    Variable

    Brain MRIMeningeal enhancementEnlarged ventricle

    >50%

  • 8/7/2019 Leptomenigeal Metastasis, MC Onco 54

    14/14

    Thank you

    Th d 27 J 2011